|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Antibody Discovery & Pre-Clinical Drug Development | ||||||||||||||||
| December 23, 2002 | ||||||||||||||||
|
Strategic Research Institute, Wyndham U.S. Grant, San Diego, CA February 25th-26th, 2003 See agenda on website: www.srinstitute.com/cs240 |
||||||||||||||||
| Organized by: | Mark Alexay | |||||||||||||||
| Invited Speakers: | Katherine Bowdish President Alexion Antibody Technologies Venkat Mukku, Ph.D. Laboratory Head, Analytical Sciences AMGEN INC Maurice Zauderer, Ph.D. President & CEO Vaccinex Inc |
|||||||||||||||
| Deadline for Abstracts: | tba | |||||||||||||||
| Registration: | 888-666-8514 | |||||||||||||||
| E-mail: | malexay@srinstitute.com | |||||||||||||||
| Posted by: | Jennifer Law | |||||||||||||||
| Host: | 12.3.58.15 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||